Madam chair, your excellencies, distinguished delegates, ladies and gentlemen,

Similar documents
Statement by the Portuguese Deputy Minister for Health. Vienna, 8 March 2010

Intervention from the World Health Organization

Madam Chair, Your Royal Highness, Excellencies, ladies and gentlemen,

Identifying Common Ground on Public Health for UNGASS 2016:

Statement. behalf of the. Federal Republic of Germany. at the. 52 nd Session of the Commission on Population and Development 1 5 April 2019

ITEM 11: SPECIAL SEGMENT. Preparations for the ministerial segment to be held during the sixty-second session of the Commission, in March 2019

ADOPTED BY THE GENERAL ASSEMBLY, THE ECONOMIC AND SOCIAL COUNCIL (ECOSOC) AND THE COMMISSION ON NARCOTIC DRUGS (CND).

ON THE SITUATION OF AND RESPONSE TO HIV IN THE REGION TOWARDS UNIVERSAL ACCESS: ACHIEVEMENTS AND CHALLENGES AND REQUIRED ACTION

Public consultation for the 2016 evaluation of the EU Drugs Strategy and Action Plan on Drugs

Resolution 59/8 Promotion of measures to target new psychoactive substances and amphetamine-type stimulants

Third Ministerial Conference of the Paris Pact Partners on Combating Illicit Traffic in Opiates Originating in Afghanistan. (Vienna, 16 February 2012)

Commission on Narcotic Drugs

Economic and Social Council

COUNCIL OF THE EUROPEAN UNION. Brussels, 30 June /04 CORDROGUE 53

CICAD INTER AMERICAN DRUG ABUSE CONTROL COMMISSION. Secretariat for Multidimensional Security

European Legal Database on Drugs

BEYOND 2008 DECLARATION

ANNUAL PROJECT PROGRESS REPORT FOR 2008 (draft)

Public consultation for the 2016 evaluation of the EU Drugs Strategy and Action Plan on Drugs

COUNCIL OF THE EUROPEAN UNION. Brussels, 6 December /02 CORDROGUE 103

Informal meeting of the Justice and Home Affairs Ministers Sopot July 2011

Public consultation for the 2016 evaluation of the EU Drugs Strategy and Action Plan on Drugs

by H.E. Ambassador Miguel Berger Deputy Permanent Representative of Germany to the United Nations

The 4 th ASEAN Ministerial Meeting on Drug Matters 29 October 2015, Langkawi, Malaysia. Chairman s Statement

Statement of the Executive Director UNODC on International Day against Drug Abuse and Illicit Trafficking

GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA. The critical need to scale up opioid substitution therapy

DRAFT OUTCOME DOCUMENT (14 JANUARY 2016) UNGASS

Press Conference 27 November Yury Fedotov, Executive Director, United Nations Office on Drugs and Crime (UNODC);

1. AFRICA GROUP (Note Verbale by Permanent Mission South Africa) The Africa Group Contribution for the UNGASS Outcome Document

COUNCIL. Official Journal of the European Union. (Information) EU Drugs Action Plan ( ) (2005/C 168/01) Introduction

COUNCIL OF THE EUROPEAN UNION. Brussels, 26 November /2/99 REV 2 LIMITE CORDROGUE 64. NOTE from : Horizontal Drugs Group

Regional Consultation on Social Determinants of Health

BAHAMAS HOUSEHOLD DRUG SURVEY THE RAPID SITUATION ASSESSMENT OF DRUG USE AND DRUG TREATMENT IN THE BAHAMAS

ADDRESS MAHAMA KAPPIAH EXECUTIVE DIRECTOR ECOWAS CENTRE FOR RENEWABLE ENERGY AND ENERGY EFFICIENCY (ECREEE)

HIV AND PEOPLE WHO INJECT DRUGS

AIDS: THE NEXT 25 YEARS XVI International AIDS Conference. Toronto, 13 August Dr Peter Piot, UNAIDS Executive Director

STATEMENT BY HON. NAKADAMA RUKIA ISANGA MINISTER FOR GENDER, LABOUR AND SOCIAL DEVELOPMENT OF THE REPUBLIC OF UGANDA UNITED NATIONS, NEWYORK

Drug Trafficking and Abuse - Impediments to development - Akira Fujino United Nations Office on Drugs and Crime (UNODC)

OICS INCB. Vienna, 7 November Fostering a united approach to the effective implementation of the three international drug control conventions

UNITED NATIONS COMMISSION ON NARCOTIC DRUGS

Launch of the INCB Annual Reports 2015

The European Food Safety Summit

The European Year of Volunteering 2011 What a Difference a Year Makes

DECLARATION ON CONTROL OF ILLICIT DRUG TRAFFICKING AND ABUSE IN AFRICA IN AFRICA ( )

United Nations Office on Drugs and Crime (UNODC)

Drug Prevention Policy in Jamaica

COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL. Towards a stronger European response to drugs

I hope this guide will be a useful tool to help us excel in all we do.

Report to the Economic and Social Council on The Need For A Balance Between Demand for and Supply of Opiates Used to Meet Medical and Scientific Needs

International cooperation against the world drug problem. of human rights overrules the harm caused by drugs. Eradication of production and

OPIUM IN AFGHANISTAN. Prepared for: Connect Model United Nations 2012 United Nations Office on Drugs and Crime Director: Geena Lee INTRODUCTION

1. RE-COMMISSIONING OF DRUG AND ALCOHOL TREATMENT AND RECOVERY SERVICES

ORGANIZATION OF AMERICAN STATES

DR. CARLOS ENCARNAÇÃO, MAYOR OF THE CITY OF COIMBRA

REVISED ELEMENTS - PROPOSED BY THE UNGASS BOARD TO THE CND FOR FURTHER CONSIDERATION - STATUS 4 November 2015

STATEMENT BY ADVOCATE DOCTOR MASHABANE DEPUTY PERMANENT REPRESENTATIVE OF THE REPUBLIC OF SOUTH AFRICA

OICS INCB REPORT OF THE INTERNATIONAL NARCOTICS CONTROL BOARD STATEMENT BY MR. RAYMOND YANS, PRESIDENT,

Republic of Turkey- Ministry of Interior-Turkish National Police- Counter Narcotics Department Date of submission: Contact person:

Bremen Conference. Responsibility and Partnership Together against HIV/AIDS. Bremen, 12 March Dr Peter Piot, UNAIDS Executive Director

G R E E C E. Madam President,

COMMISSION OF THE EUROPEAN COMMUNITIES COMMUNICATION FROM THE COMMISSION

Partnership, Cooperation and Action in the Greater Mekong Sub-region. The Memorandum of Understanding (MOU) on Drug Control

COMMISSION IMPLEMENTING DECISION. of

Economic and Social Council

The National Hepatitis C Plan - Scotland

Special Rapporteur on the right of everyone to the enjoyment of the highest attainable standard of physical and mental health, Anand Grover

Models of good practice in drug treatment in Europe. Project group

INTERNATIONAL NARCOTICS CONTROL BOARD. The International Narcotics Control Board Mandate and activities UNITED NATIONS

I. Shared responsibility in international drug control

Donne e addiction: La prospettiva di genere nella medicina delle dipendenze AULSS 9 Treviso 7 ottobre 2016

Requirements of the International Drug Control Conventions, Catherine Muganga Legal Officer, UNODC Feb 2015

QUESTIONNAIRE. Submission Information. Information for follow-up purposes. Head of International Drug Policy, Home Office

Central Committee for Drug Abuse Control. The Republic of the Union of Myanmar. National Drug Control Policy

Human Research Ethics Committee. Some Background on Human Research Ethics

Economic and Social Council

Vanuatu Country Statement

REPUBLIC OF ZAMBIA MINISTRY OF HEALTH

15074/04 JV/nt 1 DGH II

Nay Pyi Taw DECLARATION 2013

Expert consultation on improving drug statistics and strengthening the Annual Report Questionnaire (ARQ)

Pompidou Group Work Programme Drug policy and human rights: new trends in a globalised context

REMARKS BY PROF JACOB KAIMENYI, CABINET SECRETARY FOR EDUCATION DURING THE OPENING CEREMONY OF THE ACU CONFERENCE ON ENHANCING GENDER EQUITY IN THE

Dr. dr. Diah Setia Utami, SpKJ, MARS Deputy of Rehabilitation Narcotic National Board of Republic of Indonesia

Commissioner Margrethe Vestager, European Commission Rue de la Loi 170, 1049 Brussels

Our dilemma is that we hate change and love it at the same time; what we really want is for things to remain the same but get better.

Distinguished Delegates, Officials from various Ministries, Our collaborating partners, Ladies and Gentlemen,

Public health dimension of the world drug problem

Expert consultation on the improvement of drug statistics and to strengthen the Annual Report Questionnaire (ARQ) UNODC Concept Note

On behalf of UN Women, it is my honor to deliver this statement to you all, celebrating the Commemoration of the 2017 Africa Human Right Day.

January 31, Vienna Declaration. Available at: 2

NATIONAL COMMITTEE ON AIDS, DRUGS AND PROSTITUTE CONTROL OF VIETNAM

CVHS Conference 2017: UNICEF Topic Synopses

Economic and Social Council

Partnership name: Cambridgeshire & Peterborough. Novel Psychoactive Substances and Club Drugs Strategy

TB/HIV policy monitoring & advocacy - an HIV institutional perspective. Alasdair Reid

Mme. Chair, Deputy Secretary-General, Under-Secretary-General, Excellencies, Distinguished delegates, Ladies and gentlemen,

Health Programme support to the European Action Plan HIV/AIDS

Issue Paper: Monitoring a Rights based Approach: Key Issues and Suggested Approaches

MALAWI STATEMENT BY HIS EXCELLENCY CHARLES MSOSA PERMANENT REPRESENTATIVE OF THE REPUBLIC OF MALAWI TO THE UNITED NATIONS AT THE

50th session of the Commission on Narcotic Drugs March 2007 Vienna

Transcription:

toespraak Statement of the Netherlands at the 52nd session of the Commission on Narcotic Drugs, Vienna, 11 12 March 2009. delivered by Ms. Annemiek van Bolhuis, National Drug Coordinator

Madam chair, your excellencies, distinguished delegates, ladies and gentlemen, We associate ourselves with the statement made by the Czech Republic on behalf of the EU. At this high-level meeting, we are looking back on the efforts and achievements of the past ten years. However, I believe there is good reason to look back somewhat further. After all, it is now exactly a century since the foundations of our international drugs control system were laid, when the International Opium Commission convened in Shanghai. Adopting the historic perspective allows us to take a more dispassionate view, and perhaps to learn from the past. Ideally, the 'lessons learned' will be reflected in the political statement that we intend to adopt at this meeting. A review of the past century reveals both continuity and change. This continuity derives from the realization that we have a common responsibility to reduce the world drugs problem, while guaranteeing the availability of legitimate, controlled substances for therapeutic use. We have a common responsibility to counter the production of illegal drugs and the trade in those drugs, taking an appropriate and proportionate response to criminal activity, while also respecting human rights. Most importantly, we have a common responsibility to adopt a humane approach to those who

have fallen prey to drug addiction, to offer appropriate help and treatment, and to prevent disease and death. Supply and demand reduction: a balanced approach! The drugs problem is dynamic and is constantly raising new challenges for us to address. To do so effectively demands a flexible, innovative and creative approach whereby we make full use of the insights offered by scientific research and evaluation. A response that was considered adequate in the past may be of little use today. Similarly, an approach which is seen as a waste of time and resources today could become absolutely essential tomorrow. We must all rise to the challenge of finding solutions which are appropriate to the problems of the 21st century.

Madam chair, Regretfully, I must conclude that the objectives we agreed on ten years ago have not been attained. True, there have been some successes, not least in the field of judicial cooperation. Also the Netherlands plays his part in it. For example, we offer extensive international cooperation in tracing criminal financial transactions. However, we cannot claim to have made very much progress on a world scale towards the elimination of the trade in illegal drugs, or even a substantial reduction. Far from it. In many cases, the problems have merely shifted elsewhere, the increased traffic into West Africa for example, or have taken on a different form, as in the emergence of synthetic drugs. A drugs-free world is now farther away than ever. Such a world would, of course, would be ideal but we must use that word 'ideal' in its proper sense. It is a Utopia, which must not be allowed to distract us from the task in hand, that of finding solutions to the drug-related problems that exist here in the real world. But neither should it be allowed to detract from the successes that we have indeed achieved. If our efforts have led to a reduction in supply and demand, to fewer deaths, to a decrease in the incidence of HIV and to less drugrelated crime, we can justly claim that we have indeed achieved progress. It is that progress which should now be highlighted and celebrated. The last ten years of UNGASS have taught us that a balanced approach to supply and demand reduction can indeed be effective.

We have also learned that there are effective responses to the new issues and problems. Nevertheless, flexibility is required in order to apply those responses effectively. The World Health Organization and the UNAIDS partners have already demonstrated that measures such as needle exchange, substitution treatment and low-threshold counselling services can be highly effective in countering the adverse effects of drug abuse, both to individual health and to society as a whole. Such measures fall under the general heading of 'harm reduction'. The scientific debate on whether harm reduction is actually effective is now at an end. We have shown that it is. Unfortunately, however, the political debate continues. Given the aim of achieving 'system-wide coherence' between UN organizations, I find it regrettable that, although WHO and the UNAIDS partners have fully embraced harm reduction, the Commission on Narcotic Drugs still seems to consider it 'a bridge too far'. In a sense, this detracts from the work of all those dedicated professionals who devote their time and energy to tackling the real drug-related problems of real people. I cannot help but notice that the political declaration now under consideration shows some remarkable similarities to that of 1998, eleven years ago. In fact, they are virtually interchangeable. If we look at these declarations alone, it would seem that there has been absolutely no progress in the meantime. Of course, that is not the case. As I have already stated, there has been progress in both the

quality and quantity of demand reduction and, more especially, harm reduction efforts. I earnestly hope that the member states, international organizations and NGOs will continue to develop and implement evidence-based demand reduction measures, and will continue to do so with the flexibility and creativity they have shown thus far. Further pursuit of the existing effective measures, in combination with the development of alternatives, will allow us to achieve a genuinely balanced overall approach. By working together, we can indeed make a difference. I wish to assure you that the Netherlands will continue to make the fullest possible contribution. Thank you for your attention.